Nimotuzumab as a single agent palliative therapy in performance score 3 and above in EGFR expressing tumors.

Suresh Vs Attili,Dilip Pawar,Chinnababu Sunkavalli

Nimotuzumab as a single agent palliative therapy in performance score 3 and above in EGFR expressing tumors.

2017

Suresh Vs Attili
Dilip Pawar
Chinnababu Sunkavalli

e21635Background: Nimotuzumab is a humanized IgG1 monoclonal antibody against the EGFR extracellular domain that has been evaluated in solid tumors as a single agent or in combination with chemothe...

Keywords:

Nimotuzumab
Palliative Therapy
Pathology
Oncology
Internal medicine
Medicine
single agent
Monoclonal antibody

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations